Schizophrenia--time to commit to policy change.
暂无分享,去创建一个
S. Galderisi | S. Marder | W. Fleischhacker | P. Woodruff | C. Arango | W. Carpenter | M. Knapp | T. Barnes | N. Sartorius | M. Moller | Ken Duckworth | P. Arteel | Lisa Halpern
[1] M. Knapp,et al. Early intervention for first‐episode psychosis: broadening the scope of economic estimates , 2016, Early intervention in psychiatry.
[2] S. Saxena,et al. Comprehensive mental health action plan 2013-2020. , 2015, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[3] D. Streiner,et al. RISK OF SYMPTOM RECURRENCE WITH MEDICATION DISCONTINUATION IN FIRST-EPISODE PSYCHOSIS: A SYSTEMATIC REVIEW , 2014, Schizophrenia Research.
[4] M. Mimura,et al. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. , 2014, Schizophrenia bulletin.
[5] J. Veijola,et al. A systematic review and meta-analysis of recovery in schizophrenia. , 2013, Schizophrenia bulletin.
[6] M. Dempster,et al. Effectiveness of criminal justice liaison and diversion services for offenders with mental disorders: a review. , 2013, Psychiatric services.
[7] M. Harrow,et al. Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery? , 2013, Schizophrenia bulletin.
[8] M. Swartz,et al. Costs of criminal justice involvement among persons with serious mental illness in connecticut. , 2013, Psychiatric services.
[9] M. Parsonage,et al. Peer support in mental health care: is it good value for money? , 2013 .
[10] K. M. Dominguez. Mental Disorders and Vulnerability to Homicidal Death: Swedish Nationwide Cohort Study , 2013 .
[11] E. Norton,et al. The impact of changes in psychiatric bed supply on jail use by persons with severe mental illness. , 2013, The journal of mental health policy and economics.
[12] H. Goldman,et al. Economic grand rounds: financing first-episode psychosis services in the United States. , 2013, Psychiatric services.
[13] M. Mimura,et al. The cost of schizophrenia in Japan , 2013, Neuropsychiatric disease and treatment.
[14] N. Bargalló,et al. Brain Effects of Cognitive Remediation Therapy in Schizophrenia: A Structural and Functional Neuroimaging Study , 2013, Biological Psychiatry.
[15] H. Steadman,et al. Law & psychiatry: what can we say about mental health courts today? , 2013, Psychiatric services.
[16] D. Penn,et al. Psychosocial treatments for schizophrenia. , 2013, Annual review of clinical psychology.
[17] Marilyn A Winkleby,et al. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. , 2013, The American journal of psychiatry.
[18] P. Caputi,et al. Development of a short measure of psychological recovery in serious mental illness: the STORI-30 , 2013, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.
[19] R. Emsley,et al. The nature of relapse in schizophrenia , 2013, BMC Psychiatry.
[20] R. Drake,et al. Supported employment: cost-effectiveness across six European sites. , 2013, World psychiatry : official journal of the World Psychiatric Association.
[21] Norman Sartorius,et al. Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey , 2013, The Lancet.
[22] R. Stewart,et al. Diagnostic Procedures, Revascularization, and Inpatient Mortality After Acute Myocardial Infarction in Patients With Schizophrenia and Bipolar Disorder , 2013, Psychosomatic medicine.
[23] Bernadette A. Thomas,et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[24] R. Murray,et al. The Myth of Schizophrenia as a Progressive Brain Disease , 2012, Schizophrenia bulletin.
[25] T. Taskila,et al. Working with Schizophrenia: Pathways to Employment, Recovery & Inclusion , 2013 .
[26] In English,et al. The Numbers Count: Mental Disorders in America , 2013 .
[27] A. Kleinman,et al. Mental health and the global agenda. , 2013, The New England journal of medicine.
[28] C. Vega,et al. Convention on the Rights of Persons with Disabilities and Optional Protocol , 2013 .
[29] Dana Alonzo,et al. Social Support and Religion: Mental Health Service Use and Treatment of Schizophrenia , 2013, Community Mental Health Journal.
[30] C. Glendinning,et al. Personalisation through Individual Budgets: Does It Work and for Whom? , 2012 .
[31] S. Miyamoto,et al. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents , 2012, Molecular Psychiatry.
[32] Member States,et al. Convention on the Rights of Persons with Disabilities and Optional Protocol , 2012 .
[33] M. Knapp,et al. Effective Interventions in schizophrenia: the economic case. , 2012 .
[34] L. A. Pratt. Characteristics of adults with serious mental illness in the United States household population in 2007. , 2012, Psychiatric services.
[35] R. Drake,et al. Mental Health Disability , 2012 .
[36] P. Buckley,et al. Peers and peer-led interventions for people with schizophrenia. , 2012, The Psychiatric clinics of North America.
[37] Michael F. Green,et al. Functional impairment in people with schizophrenia: Focus on employability and eligibility for disability compensation , 2012, Schizophrenia Research.
[38] A. David,et al. Associations of homelessness and residential mobility with length of stay after acute psychiatric admission , 2012, BMC Psychiatry.
[39] J. Vázquez-Barquero,et al. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. , 2012, Journal of psychiatric research.
[40] M. Knapp. Mental health in an age of austerity , 2012, Evidence Based Mental Health.
[41] Kristen M. Mackowick,et al. Treatment of Tobacco Dependence in People With Mental Health and Addictive Disorders , 2012, Current Psychiatry Reports.
[42] J. Cook,et al. Results of a randomized controlled trial of mental illness self-management using Wellness Recovery Action Planning. , 2012, Schizophrenia bulletin.
[43] H. Stuart,et al. Paradigms Lost: Fighting Stigma and the Lessons Learned , 2012 .
[44] L. Schopp,et al. Relationships Among Spirituality, Religious Practices, Personality Factors, and Health for Five Different Faith Traditions , 2012, Journal of Religion and Health.
[45] John M. Davis,et al. Maintenance treatment with antipsychotic drugs for schizophrenia. , 2012, The Cochrane database of systematic reviews.
[46] W. Greiner,et al. The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective , 2012, Health Economics Review.
[47] Lars Hansson,et al. The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia , 2012, PloS one.
[48] I. Cormac,et al. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. , 2012, The Cochrane database of systematic reviews.
[49] D. Kelly,et al. The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements , 2012 .
[50] M. Lambert,et al. Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial). , 2012, The Journal of clinical psychiatry.
[51] Amy Johnson. I should be included in the census. , 2012, Schizophrenia bulletin.
[52] H. Ireys,et al. Evidence-Based Treatment for Schizophrenia and Bipolar Disorder in State Medicaid Programs , 2012 .
[53] M. Harrow,et al. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study , 2012, Psychological Medicine.
[54] R. Drake,et al. Generalizability of the Individual Placement and Support (IPS) model of supported employment outside the US , 2012, World psychiatry : official journal of the World Psychiatric Association.
[55] G. Thornicroft,et al. Anticipated discrimination among people with schizophrenia , 2012, Acta psychiatrica Scandinavica.
[56] A. Douaihy,et al. Treatment of substance abusing patients with comorbid psychiatric disorders. , 2012, Addictive behaviors.
[57] G. Thornicroft. Physical health disparities and mental illness: the scandal of premature mortality , 2011, British Journal of Psychiatry.
[58] R. Drake,et al. Why not implement supported employment? , 2011, Psychiatric services.
[59] S. Rourke,et al. Housing Status as an Independent Predictor of Functional Capacity in Patients With Schizophrenia , 2011, The Journal of nervous and mental disease.
[60] J. Os,et al. Cost of disorders of the brain in Europe 2010 , 2011, European Neuropsychopharmacology.
[61] J. Aagaard,et al. Clinical outcome of assertive community treatment (ACT) in a rural area in Denmark: A case–control study with a 2-year follow-up , 2011, Nordic journal of psychiatry.
[62] T. Laursen. Life expectancy among persons with schizophrenia or bipolar affective disorder , 2011, Schizophrenia Research.
[63] J. Os,et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010 , 2011, European Neuropsychopharmacology.
[64] D. Vancampfort,et al. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices , 2011, Psychological Medicine.
[65] L. Schmidt,et al. The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up study Dual diagnosis over 15 years , 2011, Schizophrenia Research.
[66] D. Goff,et al. The treatment of cognitive impairment in schizophrenia , 2011, Pharmacology Biochemistry and Behavior.
[67] E. Susser,et al. A Randomized Trial of Critical Time Intervention to Prevent Homelessness in Persons with Severe Mental Illness following Institutional Discharge , 2011 .
[68] P. Gorroochurn,et al. Randomized trial of critical time intervention to prevent homelessness after hospital discharge. , 2011, Psychiatric services.
[69] K. Morley,et al. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. , 2011, Archives of general psychiatry.
[70] R. Kahn,et al. Sexual Dysfunction in First-Episode Schizophrenia Patients: Results From European First Episode Schizophrenia Trial , 2011, Journal of clinical psychopharmacology.
[71] A. Mitchell,et al. Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis , 2011, British Journal of Psychiatry.
[72] L. Dixon,et al. Outcomes of a randomized study of a peer-taught Family-to-Family Education Program for mental illness. , 2011, Psychiatric services.
[73] Andrea C. Fernandes,et al. Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London , 2011, PloS one.
[74] Vyv Huddy,et al. A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes , 2012 .
[75] I. Cormac,et al. WITHDRAWN: Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. , 2011, The Cochrane database of systematic reviews.
[76] P. Delespaul,et al. Assertive Community Treatment in the Netherlands: Outcome and Model Fidelity , 2011, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[77] A. Fernandez-liria,et al. Effectiveness of Continuity-of-Care Programs to reduce time in hospital in persons with schizophrenia , 2011, Epidemiology and Psychiatric Sciences.
[78] T. Barnes. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology , 2011, Journal of psychopharmacology.
[79] H. Möller,et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care , 2011, World psychiatry : official journal of the World Psychiatric Association.
[80] N. Breitborde,et al. Multifamily Group Psychoeducation and Cognitive Remediation for First-Episode Psychosis: A Randomized Controlled Trial , 2011, BMC psychiatry.
[81] Stefan Priebe,et al. Does the Therapeutic Relationship Predict Outcomes of Psychiatric Treatment in Patients with Psychosis? A Systematic Review , 2010, Psychotherapy and Psychosomatics.
[82] J. Mari,et al. Family intervention for schizophrenia. , 2010, The Cochrane database of systematic reviews.
[83] D. Naber,et al. Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone , 2010, European Neuropsychopharmacology.
[84] R. Perkins,et al. The Individual Placement and Support approach to vocational rehabilitation for young people with first episode psychosis in the UK , 2010, Journal of mental health.
[85] John M. Davis,et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis , 2010, Schizophrenia Research.
[86] Mark Taylor,et al. Suicide and schizophrenia: a systematic review of rates and risk factors , 2010, Journal of psychopharmacology.
[87] H. Goldman. Will health insurance reform in the United States help people with schizophrenia? , 2010, Schizophrenia bulletin.
[88] Keith A Puffer. The intruder of the mind. , 2010, Schizophrenia bulletin.
[89] H. Lublin,et al. Psychiatrists’ attitude towards and knowledge of clozapine treatment , 2010, Journal of psychopharmacology.
[90] S. Gilbody,et al. Smoking cessation in severe mental illness: what works? , 2010, Addiction.
[91] B. Everitt,et al. Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis , 2010, Schizophrenia Research.
[92] M. Keshavan,et al. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. , 2010, Archives of general psychiatry.
[93] S. Watanabe-Galloway,et al. Toward successful postbooking diversion: what are the next steps? , 2010, Psychiatric services.
[94] P. McGuire,et al. Effect of early intervention on 5-year outcome in non-affective psychosis , 2010, British Journal of Psychiatry.
[95] C. Lloyd,et al. Subjective and Objective Indicators of Recovery in Severe Mental Illness: a Cross-Sectional Study , 2010, The International journal of social psychiatry.
[96] A. Mortimer,et al. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world. , 2010, Clinical schizophrenia & related psychoses.
[97] H. Ascher-Svanum,et al. Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia , 2010, BMC psychiatry.
[98] Nuno Lunet,et al. Burden of Disease and Risk Factors , 2010 .
[99] G. Remington,et al. Progress in Defining Optimal Treatment Outcome in Schizophrenia , 2010, CNS drugs.
[100] F. Dickerson,et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. , 2010, Schizophrenia bulletin.
[101] P. Weiden,et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. , 2009, The Journal of clinical psychiatry.
[102] Paolo Scotti. Recovery as discovery. , 2009, Schizophrenia bulletin.
[103] R. Warner. Recovery from schizophrenia and the recovery model , 2009, Current opinion in psychiatry.
[104] R. Kahn,et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). , 2009, The American journal of psychiatry.
[105] S. Marder,et al. Psychosocial treatments to promote functional recovery in schizophrenia. , 2009, Schizophrenia bulletin.
[106] John M Davis,et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. , 2009, The American journal of psychiatry.
[107] Norman Sartorius,et al. Global Pattern of Experienced and Anticipated Discrimination against People with Schizophrenia: a Cross-sectional Survey , 2009 .
[108] John M. Davis,et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis , 2009, The Lancet.
[109] D. Medoff,et al. Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke. , 2009, General hospital psychiatry.
[110] R. Liberman,et al. Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia. , 2009, Schizophrenia bulletin.
[111] M. Lambert,et al. Rates and predictors of remission and recovery during 3 years in 392 never‐treated patients with schizophrenia , 2008, Acta psychiatrica Scandinavica.
[112] S. Hutton,et al. Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia , 2008, The British journal of psychiatry : the journal of mental science.
[113] P. Lelliott,et al. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme , 2008, Acta psychiatrica Scandinavica.
[114] Richard A. Van Dorn,et al. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia , 2008, British Journal of Psychiatry.
[115] K. Mueser,et al. A meta-analysis of controlled research on social skills training for schizophrenia. , 2008, Journal of consulting and clinical psychology.
[116] J. Lieberman,et al. Science and recovery in schizophrenia. , 2008, Psychiatric services.
[117] Martin Knapp,et al. Paying the price: the cost of mental health care in England to 2026 , 2008 .
[118] G. Morken,et al. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia , 2008, BMC psychiatry.
[119] L. Hranov,et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial , 2008, The Lancet.
[120] Werner Kissling,et al. Peer-counseling in schizophrenia: patients consult patients. , 2008, Patient education and counseling.
[121] M. Ferriter,et al. A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia. , 2007, Schizophrenia bulletin.
[122] B. Everitt,et al. Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor , 2007, Schizophrenia bulletin.
[123] J. O. Johannessen,et al. The key to reducing duration of untreated first psychosis: information campaigns. , 2007, Schizophrenia bulletin.
[124] Mike Brady. Beating the odds--nothing is impossible, its just a road less traveled. , 2007, Schizophrenia bulletin.
[125] Nancy Vuckovic,et al. Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results. , 2008, Psychiatric rehabilitation journal.
[126] R. Drake,et al. Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment. , 2008, Psychiatric rehabilitation journal.
[127] P. Weiden. Understanding and addressing adherence issues in schizophrenia: from theory to practice. , 2007, The Journal of clinical psychiatry.
[128] N. Tarrier,et al. Needs‐based cognitive‐behavioural family intervention for patients suffering from schizophrenia: 5‐year follow‐up of a randomized controlled effectiveness trial , 2007, Acta psychiatrica Scandinavica.
[129] E. Twamley,et al. A meta-analysis of cognitive remediation in schizophrenia. , 2007, The American journal of psychiatry.
[130] H. Verdoux,et al. Time between schizophrenia onset and first request for disability status in France and associated patient characteristics. , 2007, Psychiatric services.
[131] M. Maj,et al. Physical illness and schizophrenia: a review of the literature , 2007, Acta psychiatrica Scandinavica.
[132] R. Drake,et al. The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial , 2007, The Lancet.
[133] R. Warner. Recovery From Schizophrenia: An International Perspective. A Report From the WHO Collaborative Project, the International Study of Schizophrenia , 2007 .
[134] S. Harvey,et al. Outcomes of public concern in schizophrenia , 2007, British Journal of Psychiatry.
[135] T. Aubry,et al. A review of the literature on the effectiveness of housing and support, assertive community treatment, and intensive case management interventions for persons with mental illness who have been homeless. , 2007, The American journal of orthopsychiatry.
[136] R. Rosenheck,et al. Outcomes of critical time intervention case management of homeless veterans after psychiatric hospitalization. , 2007, Psychiatric services.
[137] J. Newcomer,et al. Monitoring and managing weight gain in the mentally ill. , 2007, The Journal of clinical psychiatry.
[138] P. Weiden,et al. Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications. , 2007, The Journal of clinical psychiatry.
[139] Sarah Wild,et al. Improving access to psychological therapies , 2007 .
[140] P. Lysaker,et al. Therapeutic Alliance and Improvements in Work Performance Over Time in Patients With Schizophrenia , 2007, The Journal of nervous and mental disease.
[141] C. Coldwell,et al. The effectiveness of assertive community treatment for homeless populations with severe mental illness: a meta-analysis. , 2007, The American journal of psychiatry.
[142] M. Sajatovic,et al. Is antipsychotic medication stigmatizing for people with mental illness? , 2007, International review of psychiatry.
[143] M. Maj,et al. Physical Illness and Schizophrenia: Method , 2007 .
[144] K. Gill,et al. The concept of "being in recovery". , 2007, Psychiatric rehabilitation journal.
[145] Kim Hoppera,et al. Rethinking social recovery in schizophrenia : What a capabilities approach might offer , 2007 .
[146] M. Falagas,et al. A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories , 2006, PloS one.
[147] C. Lauber. Social inclusion of people with mental illness. , 2006 .
[148] M. Pfammatter,et al. Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. , 2006, Schizophrenia bulletin.
[149] Peter B. Jones,et al. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). , 2006, Archives of general psychiatry.
[150] K. Kotrla,et al. Disparities in hospitalization for diabetes among persons with and without co-occurring mental disorders. , 2006, Psychiatric services.
[151] S. Marder. Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness. , 2006, The Journal of clinical psychiatry.
[152] S. Leucht,et al. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. , 2006, The Journal of clinical psychiatry.
[153] R. Murray,et al. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. , 2006, Health technology assessment.
[154] K. Snyder. Kurt Snyder's personal experience with schizophrenia. , 2006, Schizophrenia bulletin.
[155] M. Swartz,et al. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. , 2006, The Journal of clinical psychiatry.
[156] Marvin Swartz,et al. Barriers to employment for people with schizophrenia. , 2006, The American journal of psychiatry.
[157] J. Bobes,et al. Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence , 2006, European Psychiatry.
[158] Peter B. Jones,et al. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. , 2005, Schizophrenia bulletin.
[159] A. Bellack. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. , 2005, Schizophrenia bulletin.
[160] M. Ruggeri,et al. Does Additional Care Provided by a Consumer Self-Help Group Improve Psychiatric Outcome? A Study in an Italian Community-based Psychiatric Service , 2005, Community Mental Health Journal.
[161] J. Lieberman,et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.
[162] R. Kessler,et al. The economic burden of schizophrenia in the United States in 2002. , 2005, The Journal of clinical psychiatry.
[163] G. Krarup,et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness , 2005, BMJ : British Medical Journal.
[164] T. Brugha,et al. The European Schizophrenia Cohort , 2005, Social Psychiatry and Psychiatric Epidemiology.
[165] M. Hummer,et al. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects , 2005, European Psychiatry.
[166] P. Tyrer,et al. Nidotherapy: making the environment do the therapeutic work , 2005 .
[167] A. Riecher-Rössler,et al. First onset and early symptomatology of schizophrenia , 1992, European Archives of Psychiatry and Clinical Neuroscience.
[168] A. Medalia,et al. What predicts a good response to cognitive remediation interventions? , 2005, Schizophrenia bulletin.
[169] Mondher Toumi,et al. The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study. , 2005, Social psychiatry and psychiatric epidemiology.
[170] L. Grossman,et al. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. , 2005, Schizophrenia bulletin.
[171] R. Murray,et al. The environment and schizophrenia: the role of cannabis use. , 2005, Schizophrenia bulletin.
[172] G. Dunn,et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis , 2004, BMJ : British Medical Journal.
[173] Bonnie L Rickelman,et al. ANOSOGNOSIA IN INDIVIDUALS WITH SCHIZOPHRENIA: TOWARD RECOVERY OF INSIGHT , 2004, Issues in mental health nursing.
[174] R. Warner. Recovery from schizophrenia , 2004 .
[175] R. McCreadie,et al. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. , 2003, The British journal of psychiatry : the journal of mental science.
[176] B. Ivarsson,et al. Integrated care in schizophrenia: a 2‐year randomized controlled study of two community‐based treatment programs , 2003, Acta psychiatrica Scandinavica.
[177] R. Drake,et al. Assertive community treatment across the Atlantic: comparison of model fidelity in the UK and USA , 2003, British Journal of Psychiatry.
[178] Plamen Nikolov,et al. Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.
[179] C. Holman,et al. Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. , 2003, The British journal of psychiatry : the journal of mental science.
[180] David Taylor,et al. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. , 2003, The Journal of clinical psychiatry.
[181] Alan I Green,et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). , 2003, Archives of general psychiatry.
[182] A. House,et al. Involving users in the delivery and evaluation of mental health services: systematic review , 2002, BMJ : British Medical Journal.
[183] W. McFarlane. Multifamily Groups in the Treatment of Severe Psychiatric Disorders , 2002 .
[184] R. Chilvers,et al. Supported housing for people with severe mental disorders. , 2002, The Cochrane database of systematic reviews.
[185] S. Leucht,et al. The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. , 2004, Schizophrenia bulletin.
[186] N. Tarrier,et al. Needs‐based cognitive‐behavioural family intervention for carers of patients suffering from schizophrenia: 12‐month follow‐up , 2001, Acta psychiatrica Scandinavica.
[187] E. Laska,et al. Recovery from psychotic illness: A 15- and 25-year international follow-up study , 2001, British Journal of Psychiatry.
[188] J. Lieberman,et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. , 2001, The American journal of psychiatry.
[189] R. McCreadie,et al. Cigarette smoking and schizophrenia , 2000 .
[190] P. Sparén,et al. Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study , 2000, BMJ : British Medical Journal.
[191] D. Braff,et al. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? , 2000, Schizophrenia bulletin.
[192] E. Latimer. Economic Impacts of Assertive Community Treatment: A Review of the Literature , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[193] G. Andrews,et al. Burden of disease , 1998, British Journal of Psychiatry.
[194] R. Rosenheck,et al. Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1998, Archives of general psychiatry.
[195] R. Drake,et al. Models of community care for severe mental illness: a review of research on case management. , 1998, Schizophrenia bulletin.
[196] R Giel,et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. , 1998, Schizophrenia bulletin.
[197] N. Sartorius. Fighting schizophrenia and its stigma , 1997, British Journal of Psychiatry.
[198] M. Moller,et al. The Three R's Rehabilitation Program: A prevention approach for the management of relapse symptoms associated with psychiatric diagnoses. , 1997 .
[199] R. Kessler,et al. Patterns and correlates of self-help group membership in the United States , 1997 .
[200] M. Goldstein. Psycho-education and family treatment related to the phase of a psychotic disorder , 1996, International clinical psychopharmacology.
[201] Michael F. Green,et al. What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.
[202] R. Dushay,et al. Psychoeducational multiple family groups: four-year relapse outcome in schizophrenia. , 1995, Family process.
[203] R. Dushay,et al. Multiple-family groups and psychoeducation in the treatment of schizophrenia. , 1995, New directions for mental health services.
[204] M. Tohen,et al. One hundred years of schizophrenia: a meta-analysis of the outcome literature. , 1994 .
[205] C. Waternaux,et al. One hundred years of schizophrenia: A meta-analysis of the outcome literature , 1993, Schizophrenia Research.
[206] J. Lieberman,et al. Duration of psychosis and outcome in first-episode schizophrenia. , 1992, The American journal of psychiatry.
[207] J. Leff,et al. A Trial of Family Therapy versus a Relatives' Group for Schizophrenia , 1990, British Journal of Psychiatry.
[208] M. Shepherd. Non-Specific Aspects of Treatment , 1989 .
[209] J. Leff,et al. A Trial of Family Therapy v. a Relatives Group for Schizophrenia , 1989, British Journal of Psychiatry.
[210] J. Strauss,et al. The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. , 1987, The American journal of psychiatry.
[211] J. Davis,et al. Maintenance therapy and the natural course of schizophrenia. , 1985, The Journal of clinical psychiatry.
[212] Phil Hodkins. A time of change , 1983 .
[213] G. Hogarty,et al. Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. , 1974, Archives of general psychiatry.